Imagine getting a powerful medicine to treat a serious condition, only to develop a new set of painful symptoms a week later. This review examined 39 patients who experienced this specific reaction, known as serum sickness, after taking Rituximab. These patients were mostly young women, with the condition appearing in those treated for issues like Multiple sclerosis or kidney problems. The reaction is a delayed immune response where the body fights the medicine itself.
The symptoms were often intense and included joint pain, fever, and skin rashes. Most patients saw these signs appear about a week after their dose, though the timing varied. Blood tests showed high levels of inflammation and low levels of certain proteins that help regulate the immune system. Fortunately, the majority of patients made a full recovery within a few days.
However, there is a critical warning for future treatments. When doctors tried giving Rituximab again to ten of these patients, six of them got sick again. This means the reaction is likely to happen if the drug is used a second time. Because of this high risk of recurrence, medical teams should approach reusing this medication with extreme caution.